Shuji Kitamura

592 total citations
14 papers, 476 citations indexed

About

Shuji Kitamura is a scholar working on Molecular Biology, Surgery and Hematology. According to data from OpenAlex, Shuji Kitamura has authored 14 papers receiving a total of 476 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 4 papers in Surgery and 3 papers in Hematology. Recurrent topics in Shuji Kitamura's work include Platelet Disorders and Treatments (3 papers), Diabetes Treatment and Management (3 papers) and Receptor Mechanisms and Signaling (3 papers). Shuji Kitamura is often cited by papers focused on Platelet Disorders and Treatments (3 papers), Diabetes Treatment and Management (3 papers) and Receptor Mechanisms and Signaling (3 papers). Shuji Kitamura collaborates with scholars based in Japan, United States and Kenya. Shuji Kitamura's co-authors include Toshimasa Tanaka, Takashi Santou, Nobuhiro Suzuki, Satoshi Sogabe, Tsuneo Yasuma, Nobuyuki Negoro, Naoyuki Kanzaki, Yoshiyuki Tsujihata, Yū Momose and Miyuki Funami and has published in prestigious journals such as Scientific Reports, Journal of Medicinal Chemistry and European Journal of Pharmacology.

In The Last Decade

Shuji Kitamura

14 papers receiving 467 citations

Peers

Shuji Kitamura
Ligaya M. Simpkins United States
Xian‐Yun Jiao United States
Guiqing Liang United States
Ravi Kurukulasuriya United States
Martin S. Domalski United States
Alan M. Birch United Kingdom
David R. Magnin United States
Sam D. Groombridge United Kingdom
Ligaya M. Simpkins United States
Shuji Kitamura
Citations per year, relative to Shuji Kitamura Shuji Kitamura (= 1×) peers Ligaya M. Simpkins

Countries citing papers authored by Shuji Kitamura

Since Specialization
Citations

This map shows the geographic impact of Shuji Kitamura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuji Kitamura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuji Kitamura more than expected).

Fields of papers citing papers by Shuji Kitamura

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shuji Kitamura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuji Kitamura. The network helps show where Shuji Kitamura may publish in the future.

Co-authorship network of co-authors of Shuji Kitamura

This figure shows the co-authorship network connecting the top 25 collaborators of Shuji Kitamura. A scholar is included among the top collaborators of Shuji Kitamura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shuji Kitamura. Shuji Kitamura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Shibata, Sachio, Satoshi Sogabe, Masanori Miwa, et al.. (2021). Identification of the first highly selective inhibitor of human lactate dehydrogenase B. Scientific Reports. 11(1). 21353–21353. 37 indexed citations
2.
Mizuta, Satoshi, Takeshi Ishikawa, Takuya Fujimoto, et al.. (2021). Lead Optimization of Influenza Virus RNA Polymerase Inhibitors Targeting PA–PB1 Interaction. Journal of Medicinal Chemistry. 65(1). 369–385. 12 indexed citations
3.
Mikami, Satoshi, Shuji Kitamura, Nobuyuki Negoro, et al.. (2012). Discovery of Phenylpropanoic Acid Derivatives Containing Polar Functionalities as Potent and Orally Bioavailable G Protein-Coupled Receptor 40 Agonists for the Treatment of Type 2 Diabetes. Journal of Medicinal Chemistry. 55(8). 3756–3776. 47 indexed citations
4.
Negoro, Nobuyuki, Shinobu Sasaki, Masahiro Ito, et al.. (2012). Identification of Fused-Ring Alkanoic Acids with Improved Pharmacokinetic Profiles that Act as G Protein-Coupled Receptor 40/Free Fatty Acid Receptor 1 Agonists. Journal of Medicinal Chemistry. 55(4). 1538–1552. 58 indexed citations
5.
Sasaki, Shinobu, Shuji Kitamura, Nobuyuki Negoro, et al.. (2011). Design, Synthesis, and Biological Activity of Potent and Orally Available G Protein-Coupled Receptor 40 Agonists. Journal of Medicinal Chemistry. 54(5). 1365–1378. 75 indexed citations
6.
Aicher, Thomas D., Yvan Le Huérou, Stephen S. Gonzales, et al.. (2010). Novel acyl coenzyme A (CoA): Diacylglycerol acyltransferase-1 inhibitors: Synthesis and biological activities of diacylethylenediamine derivatives. Bioorganic & Medicinal Chemistry. 18(7). 2785–2795. 20 indexed citations
7.
Yamamoto, Toshihiro, Hiroshi Yamaguchi, Hiroshi Miki, et al.. (2010). A novel coenzyme A:diacylglycerol acyltransferase 1 inhibitor stimulates lipid metabolism in muscle and lowers weight in animal models of obesity. European Journal of Pharmacology. 650(2-3). 663–672. 16 indexed citations
8.
Asano, Yasutomi, Shuji Kitamura, Kazuyoshi Aso, et al.. (2008). Discovery, synthesis and biological evaluation of isoquinolones as novel and highly selective JNK inhibitors (1). Bioorganic & Medicinal Chemistry. 16(8). 4715–4732. 24 indexed citations
9.
Asano, Yasutomi, Shuji Kitamura, Fumio Itoh, et al.. (2008). Discovery, synthesis and biological evaluation of isoquinolones as novel and highly selective JNK inhibitors (2). Bioorganic & Medicinal Chemistry. 16(8). 4699–4714. 75 indexed citations
10.
Kitamura, Shuji, Hideto Fukushi, Masaki Kawamura, et al.. (2001). Potent Dibasic GPIIb/IIIa Antagonists with Reduced Prolongation of Bleeding Time:  Synthesis and Pharmacological Evaluation of 2-Oxopiperazine Derivatives. Journal of Medicinal Chemistry. 44(15). 2438–2450. 30 indexed citations
12.
Kitamura, Shuji, Hideto Fukushi, Masaki Kawamura, et al.. (2001). Novel Non-Peptide GPIIb/IIIa Antagonists. Synthesis and Biological Activities of 2-[4-[2-(4-Amidinobenzoylamino)-2-(substituted)acetyl]-3-(2-methoxy-2-oxoethyl)-2-oxopiperazinyl] acetic Acids.. Chemical and Pharmaceutical Bulletin. 49(3). 258–267. 7 indexed citations
13.
Taniguchi, Shigeki, et al.. (1993). Effects of double-filtration plasmapheresis and a platelet-activating factor antagonist on the prolongation of xenograft survival.. PubMed. 11(6). 1200–8. 9 indexed citations
14.
Nakata, Masaya, et al.. (1991). Enantiospecific total synthesis of (−)-allosamizoline, and aminocyclitol moiety of the insect chitinase inhibitor allosamidin. Tetrahedron Letters. 32(39). 5363–5366. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026